<?xml version="1.0" encoding="UTF-8"?>
<p>Some factors, such as young age, smoking, persistent HIV RNA viremia, use of intravenous drugs and other comorbidities including chronic obstructive pulmonary disease, recurrent pneumonia and chronic inflammation have been identified as risk factors for lung cancer in these patients.
 <xref rid="tca13519-bib-0004" ref-type="ref">
  <sup>4</sup>
 </xref> Cancer stage, tumor characteristics and patient factors influence the outcome of lung cancer treatments. Some studies suggest that immunosuppression may not play a role in lung cancer development. Other studies show that nadir in CD4 + T cell count and length of immunosuppression may be important to take into consideration.
 <xref rid="tca13519-bib-0005" ref-type="ref">
  <sup>5</sup>
 </xref> The role of persistent HIV viral load in the pathogenesis and development of lung cancer remains undefined.
 <xref rid="tca13519-bib-0006" ref-type="ref">
  <sup>6</sup>
 </xref> Young age, male sex and extensive smoking history seem important to take into consideration.
 <xref rid="tca13519-bib-0007" ref-type="ref">
  <sup>7</sup>
 </xref>
</p>
